CompanyGraph
Realord Group Holdings Ltd.
1196 · HKEX · Hong Kong
Price data from its CUV listing on XSTU, quoted in EUR
realord.com.hkFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 8 industries, depends on 0
- ScaleMarket cap is $2.14B, above the global median of $1.15B
- PositionOperating margin is -11.2%, lower than 95% of its Conglomerates peers (median 5.3%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
16.80BHKD2.14B · vs all stocks (USD)
Revenue (TTM)
556.27MHKD70.92M · vs all stocks (USD)
Profit Margin
-160.07%vs Conglomerates peers
Beta
-0.0520xvs all stocks
52-Week Change
-35.44%vs all stocks
Market Capitalization
16.80BHKD2.14B · vs all stocks (USD)
Enterprise Value
25.91BHKD3.30B · vs all stocks (USD)
Price to Sales (TTM)
18.86xvs Conglomerates peers
Price to Book (MRQ)
5.05xvs Conglomerates peers
Enterprise to Revenue
46.57xvs Conglomerates peers
Profit Margin
-160.07%vs Conglomerates peers
Operating Margin
-11.17%vs Conglomerates peers
Return on Assets (TTM)
-0.34%vs Conglomerates peers
Return on Equity (TTM)
-24.45%vs Conglomerates peers
Revenue (TTM)
556.27MHKD70.92M · vs all stocks (USD)
Revenue per Share (TTM)
0.3860HKDUpdated Aug 19, 2026Gross Profit (TTM)
117.45MHKD14.97M · vs all stocks (USD)
EBITDA (TTM)
-79.38MHKD-10.12M · vs all stocks (USD)
Net Income (TTM)
-890.39MHKD-113.52M · vs all stocks (USD)
Operating Cash Flow (TTM)
-175.60MHKD-22.39M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-1.46BHKD-186.30M · vs all stocks (USD)
5-Year Average Dividend Yield
4.35%vs all stocks
Payout Ratio
0.00%vs Conglomerates peers
Minority Interest (Equity)
1.33BHKDFY2025 · Dec 31, 2025Revenue
556.27MHKDFY2025 · Dec 31, 2025Cost of Goods Sold
422.85MHKDFY2025 · Dec 31, 2025Gross Profit
133.42MHKDFY2025 · Dec 31, 2025Operating Income
-40.90MHKD-5.21M · vs all stocks (USD)
Pre-tax Income
-938.19MHKDFY2025 · Dec 31, 2025Income Tax Expense
-24.00MHKDFY2025 · Dec 31, 2025Net Income
-914.20MHKDFY2025 · Dec 31, 2025EBIT
-327.66MHKDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-220.00MHKDFY2025 · Dec 31, 2025Selling, General & Administrative
174.72MHKDFY2025 · Dec 31, 2025Non-operating Interest Income
10.59MHKDFY2025 · Dec 31, 2025Non-operating Interest Expense
610.53MHKDFY2025 · Dec 31, 2025EPS (Basic)
-0.6176HKDFY2025 · Dec 31, 2025EPS (Diluted)
-0.6176HKDFY2025 · Dec 31, 2025Basic Shares Outstanding
1.44BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.44BSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
23.80MHKDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00HKDFY2025 · Dec 31, 2025Operating Cash Flow
-937.87MHKDFY2025 · Dec 31, 2025Free Cash Flow
-942.48MHKDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
96.30MHKDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-938.19MHKDFY2025 · Dec 31, 2025Other Non-cash Items
578.63MHKDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
7.08MHKDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-585.39MHKDFY2025 · Dec 31, 2025Capital Expenditures
-4.61MHKDFY2025 · Dec 31, 2025Net Acquisitions
-4.26MHKDFY2025 · Dec 31, 2025Other Investing Activity
-2.80MHKDFY2025 · Dec 31, 2025Net Investing Cash Flow
-11.67MHKDFY2025 · Dec 31, 2025Long-term Debt Issuance
748.32MHKDFY2025 · Dec 31, 2025Long-term Debt Payments
-221.06MHKDFY2025 · Dec 31, 2025Other Financing Charges
27.05MHKDFY2025 · Dec 31, 2025Net Financing Cash Flow
563.97MHKDFY2025 · Dec 31, 2025Shares Outstanding
1.44BSharesUpdated Aug 19, 2026Float Shares
547.37MSharesUpdated Aug 19, 2026% Held by Insiders
62.04%vs all stocks
% Held by Institutions
1.88%vs all stocks
Total Cash (MRQ)
166.69MHKD21.25M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.1160HKDUpdated Aug 19, 2026Total Debt (MRQ)
13.32BHKD1.70B · vs all stocks (USD)
Total Debt to Equity (MRQ)
3.91xvs Conglomerates peers
Current Ratio (MRQ)
3.95xvs Conglomerates peers
Book Value per Share (MRQ)
1.44HKDUpdated Aug 19, 2026Total Assets
20.10BHKD2.56B · vs all stocks (USD)
Total Current Assets
10.36BHKDFY2025 · Dec 31, 2025Total Liabilities
16.70BHKDFY2025 · Dec 31, 2025Total Non-current Assets
9.74BHKDFY2025 · Dec 31, 2025Total Non-current Liabilities
14.08BHKDFY2025 · Dec 31, 2025Total Current Liabilities
2.62BHKDFY2025 · Dec 31, 2025Cash
96.30MHKDFY2025 · Dec 31, 2025Cash & Cash Equivalents
96.30MHKDFY2025 · Dec 31, 2025Other Short-term Investments
70.39MHKDFY2025 · Dec 31, 2025Accounts Receivable
320.45MHKDFY2025 · Dec 31, 2025Inventory
6.19BHKDFY2025 · Dec 31, 2025Accounts Payable
565.16MHKDFY2025 · Dec 31, 2025Short-term Debt
1.09BHKDFY2025 · Dec 31, 2025Long-term Debt
11.95BHKDFY2025 · Dec 31, 2025Common Stock (Book)
144.23MHKDFY2025 · Dec 31, 2025Retained Earnings
-326.73MHKDFY2025 · Dec 31, 2025Total Shareholders' Equity
3.41BHKD434.19M · vs all stocks (USD)
52-Week Low
2.88HKDUpdated Aug 19, 202652-Week High
18.34HKDUpdated Aug 19, 202652-Week Change
-35.44%vs all stocks
Beta
-0.0520xvs all stocks
50-Day MA
9.61HKDUpdated Aug 19, 2026200-Day MA
11.97HKDUpdated Aug 19, 2026Avg 10-Day Volume
27.11MSharesUpdated Aug 19, 2026Avg 30-Day Volume
22.05MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.6200HKDUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -11.2%, lower than 95% of its Conglomerates peers (median 5.3%)Significant
Operating margin: -0.11Industry median: 0.05Industry P5: -0.07Peers compared: 46.00
Profit margin is -160.1%, lower than 95% of its Conglomerates peers (median 5.2%)Significant
Profit margin: -1.60Industry median: 0.05Industry P5: -0.21Peers compared: 46.00
Return on equity is -24.5%, lower than 95% of its Conglomerates peers (median 5.5%)Significant
Return on equity: -0.24Industry median: 0.05Industry P5: -0.23Peers compared: 46.00
Current ratio is 3.95×, higher than 95% of its Conglomerates peers (median 1.62×)Significant
Current ratio: 3.95Industry median: 1.62Industry P95: 3.21Peers compared: 46.00
Debt-to-equity is 3.91×, higher than 95% of its Conglomerates peers (median 0.65×)Significant
Debt-to-equity: 3.91Industry median: 0.65Industry P95: 2.00Peers compared: 46.00
Price-to-book is 5.05×, higher than 95% of its Conglomerates peers (median 1.35×)Significant
Price-to-book: 5.05Industry median: 1.35Industry P95: 4.95Peers compared: 46.00
Structural Tensions
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 3.95Altman Z-Score: 1.02
Financial Health
Altman Z-Score 1.02: distress zoneCritical
Altman Z-Score: 1.02
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Market cap is $2.14B, above the global median of $1.15BNotable
Market cap (USD): 2,142,203,010.306Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Pediatrix Medical Group, Inc.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Addus HomeCare Corporation
Tier 1RuleThroughput-Bound ConversionProductionFlow
P3 Health Partners Inc.
Tier 1RuleThroughput-Bound ConversionRiskFlow
Chorus Limited
Tier 1RuleThroughput-Bound ConversionFlowProduction
Holding Company ADMIE IPTO S.A.
Tier 1RuleThroughput-Bound ConversionFlowProduction
Orpea
Tier 1RuleThroughput-Bound ConversionProductionFlow
Emeis SA
Tier 1RuleThroughput-Bound ConversionProductionFlow
Sienna Senior Living Inc.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Clariane SE
Tier 1RuleThroughput-Bound ConversionProductionFlow
InnovAge Holding Corp.
Tier 1RuleThroughput-Bound ConversionFlowProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shandong Longda Meishi Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shanghai Geoharbour Construction Group Co. Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated